BioSpace News Archive

Genentech snagged a new regulatory approval for its hemophilia treatment, Hemlibra. On Thursday the U.S. Food and Drug Administration approved the medication for hemophilia A patients who do not have factor VIII inhibitors.

German company Bayer AG is laying off 227 staffers at its manufacturing plant in Berkeley, California. Most of the cuts took place on October 3.

Company’s robotic technology offers access to Scarfree™ advanced endoscopy procedures.

Presentation of full TG01 phase I/II clinical trial results in resected pancreatic cancer, by Professor Daniel Palmer

Medivir AB today announced safety and efficacy data following an interim analysis of phase I data from the ongoing phase I/II study of birinapant in combination with MSD’s anti-PD-1 therapy, Keytruda®.

NeuroVive Pharmaceutical AB today announced the successful completion of biomarker analyses of samples from its clinical study in severe traumatic brain injury patients (the CHIC study) using the company’s investigational compound NeuroSTAT.

Cerecin announces first close of a new investment round and establishment of new global HQ in Singapore

Former Lacoste, Under Armor, Nautica Executive to Co-Lead Company’s Textile Sales; Brings 20+ Years of Global Textile Supply Chain Operations, Stewardship and Industry Thought Leadership to Applied DNA

Call on Innovators to Help Close the Gap in Health Care Caused by Social Factors

Oct. 4, 2018 20:26 UTC Tricida Announces Presentation of TRCA-301 Pivotal Trial Results at the American Society of Nephrology Kidney Week Meeting in San Diego, October 23 - 28 SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-dosed polymer designed to treat metabolic acidosis in patients with